Resources from the same session
A phase II single arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated Classical Kaposi Sarcoma (CKS)
Presenter: Alona Zer
Session: Mini Oral session - Sarcoma
Resources:
Slides
Webcast
Neutrophil-lymphocyte and platelet-lymphocyte ratios as robust prognostic markers in sarcomas: A population-based analysis of 3746 sarcoma patients from Hong Kong
Presenter: Sui Chun Sampson Kwan
Session: Mini Oral session - Sarcoma
Resources:
Slides
Webcast
VEGFR2 Polymorphisms as Novel Biomarker of Anti-angiogenic Therapy for Pediatric and Young Adult Sarcoma
Presenter: Qiyuan Bao
Session: Mini Oral session - Sarcoma
Resources:
Slides
Webcast